Skip to main content
Premium Trial:

Request an Annual Quote

PrimBio Exome Data Analysis

PrimBio Research Institute has launched new exome data analysis services. The service uses generated VCFs from sequenced exomes or aligned BAM files to provide exome data analysis. The company can provide consumers with QC filtered exome data sets, variant classification, molecular function of a variant, determining drug resistance or drug efficacy, using in silico tools, reporting clinical trial information of clinically significant variants, and complete references associated with findings, the company said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.